Medicines Patent Pool Responds To Critics Of Gilead Licence
The Medicines Patent Pool, which aims to increase access to affordable, high-quality medicines for HIV/AIDS patients in low and middle income countries, has issued a response to concerns about its recent deal with a large pharmaceutical company.
